EGFR and breast cancer: Therefore, these results suggest that 5a could specifically target EGFR and HER2, and the antitumor activity of 5a may act through the inhibition of EGFR and HER2 activity or other gene and/or protein (such as DR5) to induce cell cycle arrest and apoptosis in breast cancer cells.